Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 177-180

  Tschernatsch, M ^a   Singh, P ^a   Gross, O ^a   Gerriets, T ^a   Kneifel, N ^a   Probst, C ^c   Malas, S ^b   Kaps, M ^a   Blaes, F ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^c Institute of Experimental Immunology   (Germany)

Author keywords

Anti glial nuclear antibody; Paraneoplastic neurological syndromes; Peripheral neuropathy; Small cell lung cancer; SOX1

Indexed keywords

AUTOANTIBODY; CAPECITABINE; CARBOPLATIN; EPIRUBICIN; ETOPOSIDE; HU ANTIBODY; OXALIPLATIN; TRANSCRIPTION FACTOR SOX1 ANTIBODY; UNCLASSIFIED DRUG; HU ANTIGEN; TRANSCRIPTION FACTOR SOX;

ADULT; AGED; ARTICLE; AUTOINFLAMMATORY DISEASE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; EMBRYO; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; TUMOR DIAGNOSIS; ANIMAL; CLASSIFICATION; GENETIC TRANSFECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOUSE; PROCEDURES; TRANSFORMED CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; CELL LINE, TRANSFORMED; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MICE; MIDDLE AGED; PARANEOPLASTIC POLYNEUROPATHY; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; SOXB1 TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 77956341482     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.07.005     Document Type: Article

References (14)

1. Antoine J.C., Mosnier J.F., Absi L., Convers P., Honnorat J., Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999, 67:7-14.
2. Dalmau J.O., Posner J.B. Paraneoplastic syndromes affecting the nervous system. Semin Oncol 1997, 24:318-328.
3. Dalmau J., Graus F., Rosenblum M.K., Posner J.B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992, 71:59-72.
4. Graus F., Delattre J.Y., Antoine J.C., Dalmau J., Giometto B., Grisold W., Honnorat J., Smitt P.S., Vedeler Ch., Verschuuren J.J., Vincent A., Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135-1140.
5. Graus F., Vincent A., Pozo-Rosich P., Sabater L., Saiz A., Lang B., Dalmau J. Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol 2005, 165:166-171.
6. Honnorat J., Antoine J.C., Derrington E., Aguera M., Belin M.F. Antibodies to a subpopulation of glial cells and a 66kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 1996, 61:270-278.
7. Jaeckle K.A., Graus F., Houghton A., Cardon-Cardo C., Nielsen S.L., Posner J.B. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol 1985, 18:592-600.
8. Sabater L., Titulaer M., Saiz A., Verschuuren J., Gure A.O., Graus F. SOX1 antibodies are markers of paraneoplastic Lambert Eaton myasthenic syndrome. Neurology 2008, 70:924-928.
9. Titulaer M.J., Verschuuren J.J. Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms. Ann N Y Acad Sci 2008, 1132:129-134.
10. Titulaer M., Klooster R., Potman M., Sabater L., Graus F., Hegeman I.M., Thijssen P.E., Wirtz P.W., Twijnstra A., Smitt P.A., van der Maarel S.M., Verschuuren J.J. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 2009, 27:4260-4267.
11. Vural B., Chen L.C., Saip P., Chen Y.T., Ustuner Z., Gonen M., Simpson A.J., Old L.J., Ozbek U., Gure A.O. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer 2005, 103:2575-2583.
12. Wilkinson P.C. Serological findings in carcinomatous neuromyopathy. Lancet 1964, 41:1301-1303.
13. Yamada K., Watanabe M. Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells. Anat Sci Int 2002, 77:94-108.
14. Yu Z., Kryzer T.J., Griesmann G.E., Kim K., Benarroch E.E., Lennon V.A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154.